Resultados de búsqueda - Lisa Doherty
- Mostrando 1 - 11 Resultados de 11
-
1
Impact of community pharmacy diabetes monitoring and education programme on diabetes management: a randomized controlled study por Mohammed Ali, Fabrizio Schifano, Paul Robinson, G. Phillips, Lisa Doherty, P. J. Melnick, L. Laming, Alan J. Sinclair, S. Dhillon
Publicado 2012Artigo -
2
-
3
Phase II study of temozolomide, thalidomide, and celecoxib for newly diagnosed glioblastoma in adults por Santosh Kesari, David Schiff, John W. Henson, Alona Muzikansky, Debra C. Gigas, Lisa Doherty, Tracy T. Batchelor, Janina A. Longtine, Keith L. Ligon, Susan Weaver, Andrea Laforme, Naren Ramakrishna, Peter Mc L. Black, Jan Drappatz, A. S. Ciampa, Judah Folkman, Mark W. Kieran, Patrick Y. Wen
Publicado 2008Artigo -
4
Phase II study of metronomic chemotherapy for recurrent malignant gliomas in adults por Santosh Kesari, David Schiff, Lisa Doherty, Debra C. Gigas, Tracy T. Batchelor, Alona Muzikansky, A. O’Neill, Jan Drappatz, Alice Chen‐Plotkin, Naren Ramakrishna, Stephanie E. Weiss, Brenda Levy, J. Bradshaw, Jean Kracher, Andrea Laforme, Peter McL. Black, Judah Folkman, Mark W. Kieran, Patrick Y. Wen
Publicado 2007Artigo -
5
Phase I and Biomarker Study of Plerixafor and Bevacizumab in Recurrent High-Grade Glioma por Eudocia Q. Lee, Dan G. Duda, Alona Muzikansky, Elizabeth R. Gerstner, John G. Kuhn, David A. Reardon, Lakshmi Nayak, Andrew D. Norden, Lisa Doherty, Debra C. LaFrankie, Jennifer Stefanik, Trupti D. Vardam, Katrina H. Smith, Christine McCluskey, Sarah Gaffey, Tracy T. Batchelor, Rakesh K. Jain, Patrick Y. Wen
Publicado 2018Artigo -
6
A randomized, placebo-controlled pilot trial of armodafinil for fatigue in patients with gliomas undergoing radiotherapy por Eudocia Q. Lee, Alona Muzikansky, Jan Drappatz, Santosh Kesari, Eric T. Wong, Camilo E. Fadul, David A. Reardon, Andrew D. Norden, Lakshmi Nayak, Mikael L. Rinne, Brian M. Alexander, Nils D. Arvold, Lisa Doherty, Jennifer Stefanik, Debra C. LaFrankie, Sandra Ruland, Julee Pulverenti, Katrina H. Smith, Sarah Gaffey, Samantha N. Hammond, Patrick Y. Wen
Publicado 2016Artigo -
7
Phase 2 study of dose-intense temozolomide in recurrent glioblastoma por Andrew D. Norden, G. J. Lesser, Jan Drappatz, Keith L. Ligon, S. N. Hammond, E. Q. Lee, David Reardon, Camilo E. Fadul, Scott R. Plotkin, Tracy T. Batchelor, J.-J. Zhu, Rameen Beroukhim, Alona Muzikansky, Lisa Doherty, D. C. LaFrankie, Kerrington D. Smith, V. Tafoya, Rosina T. Lis, Edward C. Stack, Myrna R. Rosenfeld, Patrick Y. Wen
Publicado 2013Artigo -
8
Phase II study of monthly pasireotide LAR (SOM230C) for recurrent or progressive meningioma por Andrew D. Norden, Keith L. Ligon, Samantha N. Hammond, Alona Muzikansky, David A. Reardon, Thomas Kaley, Tracy T. Batchelor, Scott R. Plotkin, Jeffrey J. Raizer, Eric T. Wong, Jan Drappatz, Glenn J. Lesser, Sam Haidar, Rameen Beroukhim, Eudocia Q. Lee, Lisa Doherty, Debra C. LaFrankie, Sarah Gaffey, Mary Gerard, Katrina H. Smith, Christine McCluskey, Surasak Phuphanich, Patrick Y. Wen
Publicado 2014Artigo -
9
Activity of PD-1 blockade with nivolumab among patients with recurrent atypical/anaplastic meningioma: phase II trial results por Wenya Linda Bi, Lakshmi Nayak, David M. Meredith, Joseph Driver, Ziming Du, Samantha E. Hoffman, Yvonne Li, Eudocia Q. Lee, Rameen Beroukhim, Mikael L. Rinne, Ricardo McFaline-Figueroa, Ugonma Chukwueke, Christine McCluskey, Sarah Gaffey, Andrew D. Cherniack, Jennifer Stefanik, Lisa Doherty, Christina Taubert, Meghan Cifrino, D. C. LaFrankie, Thomas Graillon, Patrick Y. Wen, Keith L. Ligon, Ossama Al‐Mefty, Raymond Y. Huang, Alona Muzikansky, E. Antonio Chiocca, Sandro Santagata, Ian F. Dunn, David A. Reardon
Publicado 2021Artigo -
10
Barriers to accrual and enrollment in brain tumor trials por Eudocia Q. Lee, Ugonma Chukwueke, Shawn L. Hervey‐Jumper, John de Groot, José Pablo Leone, Terri S. Armstrong, Susan M. Chang, David Arons, Kathy Oliver, Kay Verble, Al Musella, Nicole E. Willmarth, Brian M. Alexander, Amanda Bates, Lisa Doherty, Evanthia Galanis, Sarah Gaffey, Thomas Halkin, Bret Edward Buckley Friday, Maryam Fouladi, Nancy U. Lin, David R. Macdonald, Minesh P. Mehta, Marta Peñas-Prado, Michael A. Vogelbaum, Solmaz Sahebjam, David Sandak, Martin J. van den Bent, Michael Weller, David A. Reardon, Patrick Y. Wen
Publicado 2019Revisão -
11
Clinical implementation of integrated whole-genome copy number and mutation profiling for glioblastoma por Shakti Ramkissoon, Wenya Linda Bi, Steven E. Schumacher, Lori Ramkissoon, Sam Haidar, David Knoff, Adrian M. Dubuc, Loreal Brown, Margot Burns, Jane Cryan, Malak Abedalthagafi, Yun Jee Kang, Nikolaus Schultz, David A. Reardon, Eudocia Q. Lee, Mikael L. Rinne, Andrew D. Norden, Lakshmi Nayak, Sandra Ruland, Lisa Doherty, Debra C. LaFrankie, Margaret C. Horvath, Ayal A. Aizer, Andrea Russo, Nils D. Arvold, Elizabeth B. Claus, Ossama Al‐Mefty, Mark D. Johnson, Alexandra J. Golby, Ian F. Dunn, E. Antonio Chiocca, Lorenzo Trippa, Sandro Santagata, Rebecca D. Folkerth, Philip W. Kantoff, Barrett J. Rollins, Neal I. Lindeman, Patrick Y. Wen, Azra H. Ligon, Rameen Beroukhim, Brian M. Alexander, Keith L. Ligon
Publicado 2015Artigo
Herramientas de búsqueda:
Materias Relacionadas
Internal medicine
Medicine
Oncology
Chemotherapy
Cancer research
Glioma
Surgery
Cancer
Gastroenterology
Clinical trial
Phases of clinical research
Progression-free survival
Progressive disease
Bevacizumab
Biology
Chemotherapy regimen
Meningioma
Multiple myeloma
Nursing
Pathology
Physical therapy
Radiation therapy
Randomized controlled trial
Regimen
Temozolomide
Thalidomide
Accrual
Acromegaly
Adverse effect
Alternative medicine